TheProfitWatch

LXEO - Lexeo Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
8.87 0.21 (2.37%) 0.0 (0.0%) 0.01 (0.11%) 0.01 (0.11%) 0.01 (0.11%) 0.23 (2.6%) 0.0 (0.0%) 0.02 (0.21%)

Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.6
Diluted EPS:
-0.6
Basic P/E:
-15.1333
Diluted P/E:
-15.1333
RSI(14) 1m:
58.82
VWAP:
9.08
RVol:

Events

Period Kind Movement Occurred At

Related News